scholarly article | Q13442814 |
P2093 | author name string | Dongchun Liang | |
Deming Sun | |||
Henry J Kaplan | |||
Hui Shao | |||
Aijun Zuo | |||
Mingjiazi Chen | |||
P2860 | cites work | Blockade of adenosine A2B receptors ameliorates murine colitis | Q24650596 |
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases | Q24651475 | ||
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 | ||
International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors | Q28209239 | ||
Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage | Q28214799 | ||
Determination of lymphocyte division by flow cytometry | Q28253058 | ||
Interleukin-17 family members and inflammation | Q28287876 | ||
Adenosine receptors in regulation of dendritic cell differentiation and function | Q28586835 | ||
Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease | Q29346490 | ||
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation | Q29547525 | ||
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain | Q29614225 | ||
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor | Q29619247 | ||
The A2B adenosine receptor promotes Th17 differentiation via stimulation of dendritic cell IL-6 | Q30426440 | ||
A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistence | Q30433250 | ||
Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease | Q30437360 | ||
A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. | Q30440525 | ||
Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis | Q30441350 | ||
Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition | Q30443210 | ||
Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells | Q32065053 | ||
CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression | Q33533705 | ||
Major role of gamma delta T cells in the generation of IL-17+ uveitogenic T cells | Q33829024 | ||
Attenuation of chronic pulmonary inflammation in A2B adenosine receptor knockout mice | Q33868549 | ||
Regulatory effect of gammadelta T cells on IL-17+ uveitogenic T cells | Q34135581 | ||
Characterization of Autoreactive and Bystander IL-17+T Cells Induced in Immunized C57BL/6 Mice | Q34247297 | ||
Roles of the adenosine receptor and CD73 in the regulatory effect of γδ T cells | Q34277485 | ||
Adenosine: an endogenous regulator of innate immunity | Q34286701 | ||
Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells | Q34538916 | ||
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats | Q34552239 | ||
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update | Q34701303 | ||
Effect of A2B adenosine receptor gene ablation on proinflammatory adenosine signaling in mast cells | Q34779773 | ||
Anti-inflammatory or proinflammatory effect of an adenosine receptor agonist on the Th17 autoimmune response is inflammatory environment-dependent | Q34988261 | ||
CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice | Q35015717 | ||
Activated gammadelta T cells promote the activation of uveitogenic T cells and exacerbate EAU development | Q35684372 | ||
Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. | Q35698535 | ||
Role of CD25+ Dendritic Cells in the Generation of Th17 Autoreactive T Cells in Autoimmune Experimental Uveitis | Q35981635 | ||
A2B adenosine receptor expression by myeloid cells is proinflammatory in murine allergic-airway inflammation | Q36252460 | ||
Abnormal adenosine-induced immunosuppression and cAMP metabolism in T lymphocytes of patients with systemic lupus erythematosus | Q36324955 | ||
Blocking A2B Adenosine Receptor Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis via Inhibition of IL-6 Production and Th17 Differentiation | Q36516815 | ||
Ecto-nucleoside triphosphate diphosphohydrolase 7 controls Th17 cell responses through regulation of luminal ATP in the small intestine | Q36516823 | ||
CD73 is a phenotypic marker of effector memory Th17 cells in inflammatory bowel disease | Q36566752 | ||
CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis | Q36756800 | ||
Retinoic acid inhibits CD25+ dendritic cell expansion and γδ T-cell activation in experimental autoimmune uveitis | Q36880106 | ||
IL-23 receptor expression on γδ T cells correlates with their enhancing or suppressive effects on autoreactive T cells in experimental autoimmune uveitis | Q37038620 | ||
Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). | Q37091784 | ||
A(2B) adenosine receptors in immunity and inflammation. | Q37373680 | ||
Adenosine receptors and inflammation | Q37565170 | ||
CD73: a potent suppressor of antitumor immune responses | Q38001161 | ||
CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis | Q39598074 | ||
Expression and function of adenosine receptors in human dendritic cells | Q43726407 | ||
T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response | Q45292627 | ||
IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier. | Q46339684 | ||
The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? | Q46516132 | ||
The importance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczema. | Q46970248 | ||
Adenosine and its derivatives control human monocyte differentiation into highly accessory cells versus macrophages | Q68458703 | ||
CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis | Q81386279 | ||
Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells | Q82930126 | ||
TNFR1-dependent regulation of myeloid cell function in experimental autoimmune uveoretinitis | Q84301156 | ||
P433 | issue | 4 | |
P304 | page(s) | 360-373 | |
P577 | publication date | 2015-07-30 | |
P1433 | published in | Immunity, Inflammation and Disease | Q27725961 |
P1476 | title | A2B adenosine receptor activation switches differentiation of bone marrow cells to a CD11c(+)Gr-1(+) dendritic cell subset that promotes the Th17 response | |
P478 | volume | 3 |
Q54983373 | Ability of γδ T cells to modulate the Foxp3 T cell response is dependent on adenosine. |
Q99708886 | Adenosine Signaling in Autoimmune Disorders |
Q39004042 | Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases |
Q36022631 | Blockade of Extracellular ATP Effect by Oxidized ATP Effectively Mitigated Induced Mouse Experimental Autoimmune Uveitis (EAU). |
Q38994017 | Dendritic Cells and Cancer Immunity. |
Q46132169 | Functional Conversion and Dominance of γδ T Subset in Mouse Experimental Autoimmune Uveitis |
Q39331944 | Purinergic signalling links mechanical breath profile and alveolar mechanics with the pro-inflammatory innate immune response causing ventilation-induced lung injury. |
Q36655815 | Regulation of Adenosine Deaminase on Induced Mouse Experimental Autoimmune Uveitis |
Q92999338 | The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases |
Q91840488 | The yin and yang functions of extracellular ATP and adenosine in tumor immunity |
Q38777795 | Tumor-derived factors modulating dendritic cell function |
Search more.